The posterior probability criterion function for Phase II single-arm design
Thall and Simon's criterion function for determining the trial decision boundaries based on the posterior probability.
PostP(x, n, a, b, p0)
x
: the number of responses among patients treated by the experimental drug.n
: the number of patients treated by the experimental drug.a
: the hyperparameter (shape1) of the Beta prior for the experimental drug.b
: the hyperparameter (shape2) of the Beta prior for the experimental drug.p0
: the prespecified reseponse rate.PostP(8,15,1,1,0.8)
Berry, S. M., Carlin, B. P., Lee, J. J., & Muller, P. (2010). Bayesian adaptive methods for clinical trials.
CRC press.
Thall, P. F., Simon, R. (1994). Practical Bayesian guidelines for phase IIB clinical trials. Biometrics 50 : 337-349.
Yin, G. (2013). Clinical Trial Design: Bayesian and Frequentist Adaptive Methods.
New York: Wiley.